Omazilumab: A Glimpse into Future Cancer Treatment
Omazilumab FAQ
Does omalizumab increase cancer risk?
There is no evidence that omalizumab increases your risk of developing cancers. Studies using omalizumab have observed patients for up to one year after treatment and therefore long-term side effects are unknown. Can omalizumab increase the risk of having blood clots or a stroke?
Is omalizumab safe?
Omalizumab is a very safe medication, but you will be observed initially after your first few injections. No routine blood tests are required. Before or when you have your fourth dose in your first course of treatment, the dermatology team will ask if the therapy is working (please see the section ‘How is omalizumab given?’ above).
How is omalizumab dose chosen?
Your Omalizumab dose will be chosen based on your body weight and the results of a blood test that measures your level of IgE. You will receive 1-2 injections of Omalizumab in your upper arm depending on these factors. Unless your weight changes significantly, the dose and injection schedule should not change once your treatment has started.
Does Xolair contain omalizumab?
Xolair contains the active substance omalizumab. Omalizumab is a man-made protein that is similar to natural proteins produced by the body. It belongs to a class of medicines called monoclonal antibodies. Xolair is used for the treatment of: Allergic asthma
Omazilumab References
If you want to know more about Omazilumab, consider exploring links below:
What Is Omazilumab
- https://en.wikipedia.org/wiki/Omalizumab
- https://www.drugs.com/omalizumab.html
- https://bnf.nice.org.uk/drugs/omalizumab/
- https://www.royaldevon.nhs.uk/media/c0wf4don/patient-information-leaflet-omalizumab-xolair-rde-20-207-001.pdf
- https://www.ncbi.nlm.nih.gov/books/NBK545183/
- https://go.drugbank.com/drugs/DB00043
- https://cdn.bad.org.uk/uploads/2021/12/29200255/Omazlizumab-Update-February-2018-Lay-review-June-2017-revised2.pdf
- https://www.mayoclinic.org/drugs-supplements/omalizumab-subcutaneous-route/description/drg-20065207
- https://medlineplus.gov/druginfo/meds/a603031.html
Omazilumab Information
- https://www.bad.org.uk/pils/omalizumab/
- https://patient-info.co.uk/xolair-69945/patient-leaflet
- https://www.skinhealthinfo.org.uk/wp-content/uploads/2018/11/Omalizumab-PIL-March-2023.pdf
- https://www.ema.europa.eu/en/medicines/human/EPAR/xolair
- https://www.uhnm.nhs.uk/media/1283/170710-uhnm-omalizumab-pil-17.pdf
Explore Related Topics
Immunotherapy for Asthma: Science vs. Experience
Contrast scientific evidence with personal experiences on the effectiveness of immunotherapy for asthma.